Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional studyCapsule Summary

• Autors principals: Léa Dousset, MD (Autor), Alize Pacaud, MD (Autor), Thomas Barnetche, PhD (Autor), Marie Kostine, MD, PhD (Autor), Caroline Dutriaux, MD (Autor), Anne Pham-Ledard, MD, PhD (Autor), Marie Beylot-Barry, MD, PhD (Autor), Emilie Gérard, MD (Autor), Sorilla Prey, MD, PhD (Autor), Nicolas Andreu, BSc (Autor), Katia Boniface, PhD (Autor), Julien Seneschal, MD, PhD (Autor)
• Format: Llibre
• Publicat: Elsevier, 2021-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Background: Clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 (PD-1) remain unknown. Objective: To better characterize the occurrence of vitiligo in patients receiving anti-PD-1. Methods: The present single-center ambispective cohort study included patients...